SciELO - Scientific Electronic Library Online

 
vol.39 issue5The secretory immunoglobulin A response to Mycobacterium tuberculosis in a childhood populationAnti-parvovirus B19 IgG antibody prevalence in pregnant women during antenatal follow-up and cases of non-immune hydropsis fetalis due to parvovirus B19, in the City of Rio de Janeiro author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682

Abstract

PETRY, Andrea  and  KUPEK, Emil J.. Effectiveness of recombinant DNA vaccines against hepatitis B in blood donors in an endemic region of South Brazil. Rev. Soc. Bras. Med. Trop. [online]. 2006, vol.39, n.5, pp. 462-466. ISSN 0037-8682.  http://dx.doi.org/10.1590/S0037-86822006000500008.

The objective of this work was to estimate the effectiveness of DNA recombinant anti-HBV vaccines in a retrospective cohort study of 1,012 Brazilian blood donors who completed the vaccination schedule (3 doses + booster of antibody titer <10IU/L) during the period 1998-2002. The results showed that seroconversion rates were significantly lower among the donors whose antibody titers was measured six months after completing the vaccination scheme and among older donors, particularly those aged over 50. Overall vaccine effectiveness was 88.7%, ranging from 80.6% in the oldest (50 years or over) to 91.4% among the youngest (18-30 years) donors. The booster regimen was effective at reducing the percentage of non-responders. We conclude that vaccine effectiveness was significantly better in younger blood donors and that the anti-HBs testing interval influenced the vaccine effectiveness.

Keywords : Hepatitis B; Vaccine; Anti-HBs; Effectiveness; Blood donors.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese